BioHealth News
Emergent and Rocketvax Partner on Next-Gen Product Development
GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across…
Read MoreRockville’s Cellphire Therapeutics CLPH-511 Fast Track Designation Granted
Rockville, Md. (March 11, 2025) – Cellphire Therapeutics, Inc., a clinical stage biotechnology company developing next-generation allogeneic, platelet-derived, cellular therapeutics, is excited to announce…
Read MoreIonQ Raises Over $372 Million Via At-the-Market Equity Offering Program
COLLEGE PARK, Md.--(BUSINESS WIRE)-- IonQ, Inc. (NYSE: IONQ), a leader in the quantum computing and quantum networking industries, today announced that under its “at-the-market” equity…
Read MoreSyngene Acquires its First Manufacturing Facility in Baltimore
BANGALORE, India, March 10, 2025 /PRNewswire/ -- Syngene International Limited ('Syngene'), a global contract research, development, and manufacturing organization (CRDMO), today announced the acquisition of its…
Read MoreMCCC Trends in Life Science Event: Exploring Industry Shifts, Regulations, and Growth Opportunities – Rich Bendis Keynote Speaker
The life sciences industry is constantly evolving, influenced by new technologies, regulatory changes, and market dynamics. To help professionals stay informed, the MCCC Life…
Read MoreAltimmune to Host Virtual R&D Day on March 13, 2025
GAITHERSBURG, M.D., March 06, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that it will host a virtual R&D…
Read MoreWBJ: New York health-tech company Claritev moves headquarters to Northern Virginia
By Sara Gilgore – Staff Reporter, Washington Business Journal -Mar 5, 2025 - A New York health care technology company that recently adopted a…
Read MoreQIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio
GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)-- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared…
Read MoreAscentage Pharma’s Olverembatinib Granted Breakthrough Therapy Designation for Ph+ Acute Lymphoblastic Leukemia (ALL)
ROCKVILLE, Md. and SUZHOU, China, March 05, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering,…
Read MoreUSP publishes Vulnerable Medicines List to inform efforts to reduce risk and increase supply chain reliability for patients
USP publishes Vulnerable Medicines List to inform efforts to reduce risk and increase supply chain reliability for patients Rockville, MD – The U.S. Pharmacopeia (USP)…
Read MoreTEDCO Invests in Irazú Oncology
Life sciences company developing a cost-effective production process for cancer immunotherapies COLUMBIA, Md., (March 5, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a…
Read MoreREGENXBIO Announces Closing of Strategic Partnership with Nippon Shinyaku for MPS Diseases
ROCKVILLE, Md., March 4, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the closing of its previously announced strategic partnership with Nippon Shinyaku. Under the terms of the…
Read MoreIGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer’s and Dementia Detection
POTOMAC, MD / ACCESS Newswire / March 4, 2025 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced an advancement in its Artificial Intelligence…
Read MoreGeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today an indication expansion for its industry leading…
Read MoreVenture Valkyrie: Tough Love for Women’s Health Entrepreneurs Raising Venture Money
Since I have been raising and deploying a venture fund focused on addressing health of women lately, I have had numerous occasions to be in rooms…
Read More